Drug Profile
Arsenic trioxide drug eluting stent - Beijing AmsinoMed Medical Device Co
Alternative Names: Arsenic trioxide degradable coating stent; AVILatest Information Update: 13 Oct 2021
Price :
$50
*
At a glance
- Originator Beijing AmsinoMed Medical Device Co
- Class Anti-inflammatories; Antineoplastics; Arsenicals; Ischaemic heart disorder therapies; Oxides; Skin disorder therapies; Small molecules
- Mechanism of Action Endothelial cell modulators; Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Coronary artery disease; Coronary artery restenosis
Most Recent Events
- 05 Feb 2019 Chemical structure information added
- 01 Aug 2013 Beijing AmsinoMed Medical Device initiates the phase IV PERFECT-II trial for Coronary artery disease in China (NCT02133287)
- 01 Jul 2013 Launched for Coronary artery disease in China (Intracoronary, Implant)